CompletedNCT05048563
Registry of Thiola EC Therapy
Studying Cystinuria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NYU Langone Health
- Principal Investigator
- David Goldfarb, MD, M.DNYU Langone Health
- Enrollment
- 25 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2023
Study locations (4)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- NYU Langone Health, New York, New York, United States
- Duke University, Durham, North Carolina, United States
- University of Texas Southwestern, Dallas, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05048563 on ClinicalTrials.govOther trials for Cystinuria
Additional recruiting or active studies for the same condition.